However, the gains have been short-lived as the local unit has been impacted by outflows from foreign portfolio investors (FPIs) and persistent dollar buying by state-owned banks likely on behalf of the Reserve Bank of India (RBI) prevented the rupee from rising further.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.